Here’s how organizations like Zipongo, ProMedica, and Walmart are strategizing around the food as medicine movement.

Partner, Health & Life Sciences, Oliver Wyman
Vice President, Health Transformation, Walmart
President & CEO, ProMedica
Founder and CEO

Oliver Wyman's 2018 Consumer Survey explores healthcare's supply and demand disconnect.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Women, healthcare's primary consumers, are 20 percent more likely than men are to express frustrations with the healthcare system.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

It's time to marry trust with data ownership.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Five key takeaways on healthcare’s consumer-centric shift.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Comcast and ... healthcare? We discuss a unique partnership to shake up patient-centered communication.

General Manager of Growth, Comcast NBCUniversal
President of Commercial and Consumer Markets, Independence Blue Cross
Partner, Health & Life Sciences, Oliver Wyman

What missed opportunities will incumbents one day wish they had taken advantage of? Adopting a new mentality will disrupt the industry from the inside out.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Health and wellness is shaping consumerism’s future. As potentially industry-shaking partnerships evolve, who’s best positioned to conquer the market?

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

How healthcare providers and insurers can become as valued and indispensable to customers as their smartphone.

Partner, Health & Life Sciences, Oliver Wyman
Senior Vice President & Chief Marketing Executive, Independence Blue Cross

In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More